Don’t miss the latest developments in business and finance.

USFDA completes inspection of Dr Reddys' API Hyderabad Plant 3

Image
Capital Market
Last Updated : Mar 09 2018 | 6:31 PM IST

Receives 5 observations under Form 483

Dr Reddys Laboratories announced that the audit of its API Hyderabad Plant 3 at Bollaram, Medak District, Telangana by the USFDA has been completed on 09 March 2018. The company has been issued a Form 483 with five observations.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Mar 09 2018 | 6:11 PM IST

Next Story